Takeda Pharmaceutical Company Limited
0
0
0%

Financials

Income statement

Fundamentals currency is JPY
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 6.1B 6.0B 5.8B 6.3B
Cost of revenue 2.1B 2.1B 2.1B 2.3B
Gross profit 4.0B 3.9B 3.7B 4.0B
Operating expense
Research & development 882.7M 786.5M 1.2B 930.3M
Selling general and admin 1.4B 1.4B 1.6B 1.5B
Other operating expenses 238.1M 33.0M -613.1M 799.4M
Operating income 377.1M 1.0B 374.7M -122.7M
Non operating interest income
Income 242.7M 403.2M -44.6M -38.2M
Expense 454.4M 585.7M -122.6M 172.7M
Other income expense -11.4M -2.9M -908.0M 478.0M
Pretax income 154.0M 823.4M -586.5M 144.3M
Tax provision 218.1M 144.0M -23.0M 14.1M
Net income -64.1M 679.3M -563.6M 130.3M
Basic EPS 79.4
Diluted EPS 78.2
Basic average shares 8.6M
Diluted average shares 8.7M
EBITDA 1.7B 2.4B 400.9M 1.3B
Net income from continuing op. -64.1M 679.3M -563.6M 130.3M
Minority interests -393.6K -196.8K -311.6K -251.4K
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 2 hours 42 minutes

14:52
00:00
08:55
17:35
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 08:55
Main market
08:55 - 17:35
Post-market
17:35 - 17:50
All times are displayed in the Europe/Vienna timezone (CET, UTC+01:00).